Hospital Management
RSSArticles
-
Problem of surgery on the wrong site and retained objects won’t go away
Wrong-site surgery errors persist even after years of concerted efforts to avoid them, and some of the standard prevention policies and procedures might not be effective enough. Some facilities are finding other ways to prevent this never event and other errors.
-
Recommendations for bronchoscope reprocessing
The FDA has issued safety recommendations for healthcare facilities that reprocess flexible bronchoscopes, the American Hospital Association recently reported.
-
Alarm sounded: Recurrent problems in reprocessing
Warning that continuing infection control lapses are endangering patients, the CDC and the FDA recently issued a joint alert calling for healthcare facilities to review policies and practices in cleaning and processing reusable medical devices.
-
Growing number of elderly brings issues with LOS, readmissions
In this first part of a two-part series on elderly patients, we discuss problems that cause delirium in and unanticipated hospitalization of seniors. In next month’s issue, we discuss more specifics about the problems, as well as solutions from experts in the field. -
Incidental findings in research subjects: It’s complicated
Incidental findings in research subjects — which can be completely benign or herald significant health problems — raise thorny issues for IRBs that are best addressed through informed consent and a detailed contingency plan.
-
Comments, concerns on ANPRM draft may forecast NPRM reaction
A recently published analysis of comments on biospecimen research submitted in response to the 2011 Advance Notice of Proposed Rulemaking indicates institutional review boards and researchers are facing a series of “tradeoffs” that will likely carry over in the next iteration of the human research Common Rule.
-
Changes to Common Rule would change exemptions
The NPRM of the Common Rule in human research protection provides for eight categories of exemption to IRB reviews and discusses a tool that investigators and others could use to determine whether a study is exempt.
-
IC under revised Common Rule is transparent, tightened
Common Rule changes under the Notice of Proposed Rulemaking could impact how IRBs handle the informed consent process, by both increasing transparency and imposing stricter new requirements about information provided to prospective subjects.
-
Shaking the IRB Foundation
“I think the local IRB has seen its day."
-
CDC, FDA sound alarm on recurrent problems in reprocessing
Warning that continuing infection control lapses are endangering patients, the CDC and the FDA recently issued a joint alert calling for healthcare facilities to review policies and practices in cleaning and processing reusable medical devices.